Work

Relapse prevention with second generation tyrosine kinase inhibitors for Ph+ve acute leukemia after allogenic stem cell transplantation.

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.15_suppl.7050

Authors: Faiz K. Anwer, Zabih Warraich, Atif Sohail, Theresa Thai, Azka Latif, Vikas Kapoor, Keri Renee Maher, Faiza Hassan Warraich, Sami Warraich, Zeeshan Baig, Adeela Mushtaq, Pavan Tenneti, Ali McBride

Institutions: University of Arizona, St. Joseph’s University Medical Center, Banner - University Medical Center Tucson, University of Arizona Cancer Center

Language: English

Topic: Acute Lymphoblastic Leukemia research

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2891769725

Cites:

Cited by:

Related to: 10